Q3 2025 Management View Mark Casale, Chairman and CEO, highlighted the company's resilience, stating that "our performance this quarter again underscores the resilience of our business as we continue ...
Jeff Castor faced nearly $54,000 in denied claims for mental health treatment sought for a family member, despite prior ...
Medicare has selected the technology vendors who'll run its prior authorization pilot in New Jersey, Ohio, Oklahoma, Texas, ...
International General Insurance (IGIC) announced that its board of directors has approved a new repurchase authorization of up to 5M of the ...
The aggravating prior authorization process includes one step that merits scrutiny and potentially regulatory action: the ...
Prior authorization is a barrier to accessing medications for opioid use disorder (MOUD). Although private insurance covered about one-third of patients with OUD in 2023, the understanding of prior ...
A new study from Tulane University found that, over the past decade, more states have moved to make it easier for people with opioid use disorder to get potentially life-saving medication.
Twenty-two states now prohibit prior authorization for opioid use disorder medications such as methadone, buprenorphine and naltrexone, up from two states in 2015. The upward trend signals a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback